High-titer antibody to hepatitis b surface antigen before liver transplantation can prevent de novo hepatitis b infection

Journal of Pediatric Gastroenterology and Nutrition

Volumn 48, Issue 2, 2009, Pages 203-208

  Su, Wei Ju ^a   Ho, Ming Chih ^a   Ni, Yen Hsuan ^a   Chen, Huey Ling ^a   Hu, Rey Heng ^a   Wu, Yao Ming ^a   Chang, Mei Hwei ^a   Lee, Po Huang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti HBs titer; De novo hepatitis B; Liver transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; TACROLIMUS; ANTIVIRUS AGENT; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN;

ADOLESCENT; ALLOGRAFT; ANTIBODY TITER; ARTICLE; CHILD; CORTICOSTEROID THERAPY; DE NOVO HEPATITIS B; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; INFECTION RISK; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TAIWAN; VACCINATION; BLOOD; GRAFT SURVIVAL; IMMUNOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; RISK FACTOR;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INCIDENCE; INFANT; LIVER TRANSPLANTATION; MALE; RECURRENCE; RISK FACTORS;

EID: 66149139468     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181819ad4     Document Type: Article

References (27)

1. Castells L, Vargas V, Rodriguez F, et al. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation. Liver Transpl 2002;8:892-900.
2. Munoz SJ. Use of hepatitis B core antibody-positive donors for liver transplantation. Liver Transpl 2002;8:S82-7.
3. Dodson SF, Bonham CA, Geller DA, et al. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999;68:1058-61.
4. Lin CC, Chen CL, Conceero A, et al. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients. Am J Transplant 2007;7:195-200.
5. Liu CJ, Lo SC, Kao JH, et al. Transmission of occult hepatitis B virus by transmission to adult and pediatric recipients in Taiwan. J Hepatol 2006;44:39-46.
6. Roche B, Samuel D, Gigou M, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997;26:517-26.
7. Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997;113:1668-74.
8. Chen YS, Wang CC, de Villa VH, et al. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core positive donors. Clin Transplant 2002; 16:405-9.
9. Takemura N, Sugawara Y, Tamura S, et al. Liver transplantation using hepatitis B core antibody-positive grafts: review and University of Tokyo experience. Dig Dis Sci 2007;52:2472-7.
10. Prieto M, Gómez MD, Berenguer M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001;7:51-8.
11. Ni YH, Chang MH. The ways paved for prophylaxis against de novo hepatitis B virus infection after liver transplantation: still many stones left unturned. Pediatr Transplant 2006; 10:405-7.
12. Uemoto S, Sugiyama K, Marusawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998; 65:494-9.
13. Lee KW, Lee DS, Lee HH, et al. Prevention of de novo hepatitis B infection from HBcAb-positive donors in living donor liver transplantation. Transpl Proc 2004;36:2311-2.
14. Chang SH, Suh KS, Yi NJ, et al. Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation. Hepatology 2003;37:1329-34.
15. Holt D, Thomas R, Van Thiel D, et al. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. Arch Surg 2002;137:572-5.
16. Nery JR, Nery-Avila C, Reddy KR, et al. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivu-dine. Transplantation 2003;75:1179-86.
17. Chazouilleres O, Mamish D, Kim M, et al. ''Occult'' hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-6.
18. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002;2:479-86.
19. Chalasani N, Smallwood G, Halcomb J, et al. Is vaccination against hepatitis B infection indicated in patients waiting for or after ortho-topic liver transplantation? Liver Transpl Surg 1998;4:128-32.
20. Carey W, Pimentel R, Westveer MK, et al. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol 1990;85:1590-2.
21. Loinaz C, de Juanes JR, Gonzalez EM, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997;44:235-8.
22. Horlander JC, Boyle N, Manam R, et al. Vaccination against hepatitis B in patients with chronic liver diseases awaiting liver transplantation. Am J Med Sci 1999;318:304-7.
23. Arslan M, Wiesner RH, Sievers C, et al. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver diseases. Liver Transpl 2001;7:314-20.
24. Ni YH, Chang MH, Chen PJ, et al. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 2007;132:2340-5.
25. Barcena MR, Garcia-Hoz F, Vazquez RM, et al. Prevention of de novo hepatitis B infection in liver allograft recipients with previous hepatitis B infection or hepatitis B vaccination. Am J Gastroenterol 2002;97:2398-401.
26. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-9.
27. Echevarria JM, Avellon A. Hepatitis B virus genetic diversity. J Med Virol 2006;78 (Suppl 1):S36-42.